CNBC’s Jim Cramer sits down with CVS Health CEO David Joyner to discuss the company's investor day, how healthcare technology ...

CNBC’s Jim Cramer explains why he is keeping an eye on shares of CVS Health. White House responds to Pope Leo’s rebuke of ...

CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...

CVS Health’s narrative has shifted with a slightly higher fair value estimate, nudging from about $91.50 to roughly $92.40 ...

The healthcare giant expects its turnaround efforts to pay off as it raised its full-year outlook and expects that momentum ...

CVS Health on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady ...

It’s part of a larger battle between Louisiana officials and big health care companies over prescription drug prices.

CVS Health Stock Gains on Guidance Raise. How It Expects to Perform in 2025 and Beyond.

BATON ROUGE, La. (WAFB) - Louisiana has settled two federal lawsuits against CVS Health Corporation and its pharmacy benefit ...

Discover why CVS Health Corporation is a top S&P 500 performer in 2025. See bullish forecasts, strong growth, and a new price ...

CVS Health raises its 2025 revenue outlook as Bank of America highlights stronger margins, new tech investments, and momentum ...